Intercept Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session.

This stock, which remained volatile and traded within the range of $108.52 –$119.59 in the past one-month time frame, witnessed a sharp increase on Friday.

The company has seen seven positive estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past month, suggesting that more solid trading could be ahead for Intercept Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Intercept Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESPis 0.00%.

Intercept Pharmaceuticals, Inc. Price and Consensus

A better-ranked stock in the  Medical - Biomedical and Geneticsindustry is VIVUS, Inc.(VVUS), which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ICPT going up? Or down? Predict to see what others think: Up or Down

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look. See the pot trades we're targeting>>